These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30832574)

  • 1. Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction.
    Henriksson R; Ulvenstam A; Söderström L; Mooe T
    BMC Cardiovasc Disord; 2019 Mar; 19(1):51. PubMed ID: 30832574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction.
    Henriksson R; Björklund F; Mooe T
    PLoS One; 2019; 14(5):e0216404. PubMed ID: 31059535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic stroke rates decrease with increased ticagrelor use after acute myocardial infarction in patients treated with percutaneous coronary intervention.
    Ulvenstam A; Henriksson R; Söderström L; Mooe T
    Eur J Prev Cardiol; 2018 Jul; 25(11):1219-1230. PubMed ID: 29929389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Edfors R; Sahlén A; Szummer K; Renlund H; Evans M; Carrero JJ; Spaak J; James SK; Lagerqvist B; Varenhorst C; Jernberg T
    Heart; 2018 Oct; 104(19):1575-1582. PubMed ID: 29574413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.
    Baber U; Leisman DE; Cohen DJ; Gibson CM; Henry TD; Dangas G; Moliterno D; Kini A; Krucoff M; Colombo A; Chieffo A; Sartori S; Witzenbichler B; Steg PG; Pocock SJ; Mehran R
    Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004945. PubMed ID: 30606052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, trends, and predictors of ischemic stroke 30 days after an acute myocardial infarction.
    Kajermo U; Ulvenstam A; Modica A; Jernberg T; Mooe T
    Stroke; 2014 May; 45(5):1324-30. PubMed ID: 24692479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data.
    Kim C; Shin DH; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Hong MK; Park J; Lee H; Kim DS; Oh SK; Jang Y
    J Cardiol; 2019 Mar; 73(3):191-197. PubMed ID: 30770037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome.
    Spoendlin J; Gagne JJ; Lewey JJ; Patorno E; Schneeweiss S; Desai RJ
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1361-1370. PubMed ID: 30379372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Ticagrelor Compared with Clopidogrel in Patients with End-Stage Renal Disease with Acute Myocardial Infarction.
    Lee CH; Tsai TH; Lin CJ; Hsueh SK; Chung WJ; Cheng CI
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):325-334. PubMed ID: 30746615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke in Patients With Peripheral Artery Disease.
    Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
    Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction.
    Ulvenstam A; Kajermo U; Modica A; Jernberg T; Söderström L; Mooe T
    Stroke; 2014 Nov; 45(11):3263-8. PubMed ID: 25236874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Use of Ticagrelor After Myocardial Infarction Is Not Associated With Intracranial Hemorrhage.
    Graipe A; Söderström L; Mooe T
    Stroke; 2018 Dec; 49(12):2877-2882. PubMed ID: 30571411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
    Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
    Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK;
    J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.
    Fu A; Singh K; Abunassar J; Malhotra N; Le May M; Labinaz M; Glover C; Marquis JF; Froeschl M; Dick A; Hibbert B; Chong AY; So DY;
    Clin Cardiol; 2016 Jan; 39(1):19-23. PubMed ID: 26748815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
    Zanchin T; Temperli F; Karagiannis A; Zanchin C; Räsänen M; Koskinas KC; Stortecky S; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Billinger M; Heg D; Pilgrim T; Valgimigli M; Windecker S; Räber L
    Circ Cardiovasc Interv; 2018 May; 11(5):e006132. PubMed ID: 29748219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
    Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
    Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction.
    Altıntaş B; Altındağ R; Bilge Ö; Baysal E; Öztürk Ö; Yaylak B; Ede H; Karahan MZ; Burak C; Tanboğa İH
    Int J Cardiol; 2019 Jul; 287():19-26. PubMed ID: 30979602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention.
    Piqueras-Flores J; Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Abellán-Huerta J; Lozano-Ruiz Poveda F
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):56-59. PubMed ID: 30383607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.